Navigating Biopharma's Next Frontier: McKinsey's Life Sciences Conference 2025
Description
This IDC Perspective shares insights generated from the McKinsey Life Sciences Conference held in New York on July 30 and 31 on the evolving biopharma landscape, the impact of agentic AI, launch strategies, and women's health."The life sciences industry is experiencing massive disruption, and it is exploring every avenue possible to sustain growth and scale innovation. While investments in agentic AI are scaling, that alone is not the answer. Beyond the tech, the greatest innovation lies in transforming organizational culture. That's the real disruptor," said Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology, IDC.
Table of Contents
7 Pages
Executive Snapshot
Situation Overview
The Evolving Biopharma Landscape
Navigating the Shift to Agentic AI
Healthcare Reform
Her Health, Our Future: The Crucial Importance of Women's Health
The New Pharma Playbook: Reinventing Commercial Models for a Changing Landscape
Advice for the Technology Buyer
Learn More
Related Research
Synopsis
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
